Although we have not measured intra-hepatic expression of IL-15 in NAFLD patients, the previous reports support the possibility that up-regulated IL-15 might result in higher expression of NKG2D in the liver of patients with NAFLD. Here, KLRK1 is linked to metabolic dysfunction-associated steatotic liver disease.